During the past decade, Ohio State University Clinical Trials Management Office conducted 9 clinical trials. In the 10-year time frame, 9 clinical trials started and 6 clinical trials were completed, i.e. on average, 66.7% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 5 clinical trials were completed. i.e. 500% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ohio State University Clinical Trials Management Office" #1 sponsor was "Celgene" with 3 trials, followed by "AnaptysBio, Inc." with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "InflaRx GmbH" with 1 trials sponsored and "Neurocrine Biosciences" with 1 trials sponsored. Other sponsors include -2 different institutions and companies that sponsored additional 8 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ohio State University Clinical Trials Management Office" #1 collaborator was "Genmab" with 1 trials as a collaborator, "Hexal AG" with 1 trials as a collaborator, "Iqvia Pty Ltd" with 1 trials as a collaborator and "Voyager Therapeutics" with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Ohio State University Clinical Trials Management Office" are "Ulcerative Colitis" (2 trials), "Atopic Dermatitis" (1 trials), "Colitis, Ulcerative" (1 trials), "Crohn's Disease" (1 trials) and "Fallopian Tube Cancer" (1 trials). Many other conditions were trialed in "Ohio State University Clinical Trials Management Office" in a lesser frequency.

Most popular intervention types in "Ohio State University Clinical Trials Management Office" are "Drug" (9 trials), "Biological" (2 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "RPC1063" (3 trials), "Adalimumab" (1 trials), "Adalimumab placebo" (1 trials) and "GDC-0853" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ohio State University Clinical Trials Management Office" are 9 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Ohio State University Clinical Trials Management Office". undefined are not yet recruiting, undefined are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 6 completed trials in Ohio State University Clinical Trials Management Office, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Ohio State University Clinical Trials Management Office, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".